Intra Cellular Therapies reported $14.22M in Trade Creditors for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Creditors Change
Acadia Pharmaceuticals ACAD:US USD 10.01M 1.85M
ALKERMES ALKS:US USD 33.2M 6.85M
Aptinyx Inc APTX:US USD 474K 1.63M
Biogen BIIB:US USD 383.2M 51.6M
Bristol Myers Squibb BMY:US USD 2.6B 287M
Cytokinetics CYTK:US USD 14.43M 351K
Esperion Therapeutics ESPR:US USD 18.58M 5.75M
Halozyme Therapeutics HALO:US USD 18.17M 5.93M
Intra Cellular Therapies ITCI:US USD 14.22M 3.47M
JAZZ PHA JAZZ:US USD 102.25M 28.09M
Marinus Pharmaceuticals MRNS:US USD 1.62M 1.68M
Minerva Neurosciences NERV:US USD 533K 987K
Nektar Therapeutics NKTR:US USD 5.33M 7.02M
Novartis NVS:US USD 4.69B 276M
Supernus Pharmaceuticals SUPN:US USD 16.02M 19.5M
Vanda Pharmaceuticals VNDA:US USD 5.58M 36K